3 Facts : Skin Changes During Pregnancy and Considerations for the Use of Safe Active Ingredients
Skin changes during pregnancy are not just a personal issue, but also a crucial concern in skincare product development. Consumers are increasingly selective about the ingredients they use, especially regarding the safety of active ingredients for pregnant women.
Therefore, manufacturers need to ensure that each formulation is not only effective but has also undergone proper testing to ensure its safety.
Table of Content :
- Skin Changes During Pregnancy
- Manifestations of Physical Changes in the Skin
- Risks of Active Ingredients to the Fetus
- Appropriate Diagnostic and Management Approaches
- Safe Alternatives of Active Ingredients
Skin Changes During Pregnancy
Pregnancy is a period characterized by various physiological changes in the body, including alterations in skin condition. Skin that was previously normal may become more sensitive, oily, dry, or even develop hyperpigmentation.
These changes are generally influenced by hormonal fluctuations, particularly increased levels of estrogen and progesterone, which play a role in regulating sebum production, skin elasticity, and melanocyte activity. In addition to hormonal factors, changes in the immune system and blood circulation also contribute to skin condition during pregnancy.
Manifestations of Physical Changes in the Skin
One of the most common physical changes during pregnancy involves the skin. Conditions such as dryness, dullness, acne, and hyperpigmentation are frequently experienced. Melasma, for instance, is a form of hyperpigmentation that commonly appears on sun exposed areas of the face.
This condition is triggered by hormonal changes that stimulate melanin production. In addition, striae gravidarum, or stretch marks, often develop due to excessive skin stretching beyond its elastic capacity, resulting in disruption of collagen structures.
These changes often lead to the use of skincare products to address various concerns. However, product selection must be carried out with caution, as not all active ingredients are safe for use during pregnancy.
Read also :
Amino Acids in Skincare: Can Microorganisms Unlock the Future of Cosmetic Ingredients?
Risks of Active Ingredients to the Fetus
Pregnant individuals are particularly vulnerable to certain active ingredients, as some substances can be absorbed through the skin and enter systemic circulation. These substances may cross the placenta and potentially affect fetal development. Furthermore, certain compounds may also be distributed through breast milk after childbirth.
One group of ingredients that should be avoided is retinoids, including retinol and its derivatives. These compounds are known to have teratogenic potential, as they can interfere with cell growth regulation and embryonic tissue differentiation. Exposure to retinoids during pregnancy has been associated with an increased risk of abnormalities in the nervous system, heart, and craniofacial structures of the fetus.
Hydroquinone is another ingredient that should be avoided due to its relatively high rate of systemic absorption. Although direct evidence of harm to the fetus remains limited, its high absorption rate raises concerns regarding potential risks.
Salicylic acid in high concentrations, particularly in the form of chemical peels, also requires caution. While low concentration topical use is generally considered safe, excessive exposure may increase the risk of undesirable systemic effects. Additionally, other substances such as formaldehyde, phthalates, and certain essential oils in high concentrations may also pose risks to both the mother and fetus.
Appropriate Diagnostic and Management Approaches
In addressing skin conditions during pregnancy, accurate diagnosis is essential to ensure appropriate treatment. Skin changes may result from normal physiological processes, exacerbation of pre existing dermatological conditions, or pregnancy specific dermatoses. Therefore, a multidisciplinary approach involving obstetricians and dermatologists is highly recommended to ensure the safety of both mother and fetus.
Safe Alternatives of Active Ingredients
Despite various restrictions, several active ingredients are considered safe for use during pregnancy. Azelaic acid is an effective option for managing hyperpigmentation and acne. It works selectively on affected areas without impacting normal skin and has minimal systemic absorption.
Vitamin C and niacinamide are also widely used due to their antioxidant properties and ability to brighten the skin. Both ingredients have favorable safety profiles, as they are not associated with teratogenic effects and are minimally absorbed into the body.
Hyaluronic acid is another safe ingredient, particularly for maintaining skin hydration. Its large molecular size limits its penetration into systemic circulation, thereby minimizing potential risks to the fetus.
Mineral based sunscreens containing zinc oxide and titanium dioxide are also recommended, as they act by physically blocking ultraviolet radiation without being absorbed into the skin.
Conclusion
Skin changes during pregnancy are common and primarily influenced by hormonal and physiological factors. While skincare can help manage various skin concerns, it must be used selectively and with caution. Certain active ingredients pose potential risks to the fetus due to their ability to be absorbed and affect embryonic development.
On the other hand, some ingredients are considered relatively safe due to their low absorption rates or the body’s ability to metabolize them without causing harm. Therefore, a thorough understanding of product ingredients, along with consultation with healthcare professionals, is essential in maintaining the health and safety of both mother and fetus during pregnancy.
Conduct safety, content, and toxicity testing with IML Testing and Research to ensure your products are proven, reliable, and industry compliant.
Author : Delfi
Editor : Alphi
References :
Bio LL, Cies JJ. Lack of pregnancy warnings on over-the-counter dermatologic products containing potentially harmful hydroquinone. J Perinatol. 2017;37(7):778–81.
Davis, M., Smith, S., Skaggs, B., Gradwohl, K., Griffin, J., & Mauskar, M. M. (2026). Narrative Review of Skin and Pregnancy: Dermatologic manifestations and medication management during pregnancy. Dermatology and Therapy.
